retatrutide pros and cons Cons: What Canadians Need to Know Retatrutide 5mg - MEDICA DEPOT

Retatrutide in the UK: How People Are Accessing It and the Risks Retatrutide, the investigational triple hormone receptor agonist developed by Eli Lilly, has attracted significant public interest following promising Phase 2 trial data but it remains unlicensed in the UK

Working with a provider who takes a whole-person approach combining medication with lifestyle guidance, nutrition support, and regular check-ins gives you the best chance at lasting results, regardless of what happens with any single drug's coverage

doi: 10.1056/NEJMoa1509225 [DOI] [PubMed] [Google Scholar] 251

GLP-1 receptor agonists: A novel pharmacotherapy for binge eating (Binge eating disorder and bulimia nervosa)

Can I use it long-term

adults have taken a GLP-1 drug for weight loss or to treat a chronic condition, about half of people will stop taking it within a year